Abbott Laboratories (ABT) stock analysis
A free, instant KC Score and technical read on Abbott Laboratories, from the last 12 months of price data.
Abbott Laboratories
Mixed / range-bound — no clear trend in the data right now.
3-month +9.3%, 6-month -2.6%.
Price is below its 50-day and below its 200-day average; 50DMA above 200DMA.
Trading 25% below its 52-week high — 36% of the way up its yearly range.
Annualised volatility ~27% — moderately choppy.
The KC Score is a transparent 0–100 read of Abbott Laboratories's recent price behaviour, built from ~12 months of daily closing prices. Momentum weighs 3- and 6-month returns; Trend checks price against its 50- and 200-day moving averages; Range strength measures where it sits in its 52-week range; Stability reflects volatility. It is a descriptive technical summary — not a forecast, price target, or recommendation to buy or sell. Markets change daily; re-check before acting and do your own research.
What the KC Score says about Abbott Laboratories
Abbott Laboratories (ABT) currently carries a KC Score of 45 out of 100 — a grade of C. In plain terms: mixed / range-bound — no clear trend in the data right now. The score is a transparent, rules-based read of roughly the last twelve months of Abbott Laboratories's daily closing prices. It describes momentum, trend, range position and stability — it is not a buy or sell recommendation, and it knows nothing about Abbott Laboratories's valuation, earnings or news. At the last hourly update the stock traded near USD101.29, up 0.2% on the session, sitting 36% of the way up its 52-week range and about 25.2% below its 52-week high.
Momentum scores 59 out of 100. Over the past three months Abbott Laboratories has moved 9.3%, and -2.6% over six months — a mixed picture across the two windows. On trend (24/100), the price is below its 50-day moving average and below its 200-day average. Trading below both averages is the shape the model reads as a downtrend.
Range position scores 36/100: at 36% of its 52-week band, Abbott Laboratories is trading toward the lower end of where it has been over the last year. Stability scores 83/100, off annualised volatility of about 27% — relatively low for a single stock. Lower volatility means steadier day-to-day movement, though it is never a guarantee against a large fall.
For a long-term investor, one stock's score matters far less than the system around it: keeping costs low, staying diversified, and giving compounding time to work. Treat ABT's reading as a single input, not a verdict, and compare it against other Healthcare names rather than in isolation. The math always wins — a low-cost, broadly diversified portfolio held for years reliably beats reacting to any one score, including this one.
Commission-free ISAs & general accounts. Not a recommendation — compare fees and features yourself.
Some links are affiliate links — we may earn a commission at no extra cost to you. This never affects our analysis.
Abbott Laboratories (ABT) — frequently asked
Is the KC Score a buy or sell signal?
No. It is an educational, rules-based description of recent price behaviour — momentum, trend, range and stability. It carries no view on valuation, fundamentals or news, and nothing here is financial advice. Your capital is at risk.
What data is the score based on?
Roughly the last twelve months of daily closing prices from public market data. The same transparent formula is applied to every stock, so scores are comparable across the site.
How often does it update?
Prices and the score refresh hourly, automatically. You may see a slightly different reading later in the day as new prices come in.
Hold ABT? See what your whole portfolio says about you.
AlphaScore reads your real trade history and names your investor type — your edge, your blind spots, your next moves. Your statement never leaves your device. Free.